AR215643A1 - Procedimiento para la elaboracion de compuestos de 4-(3-amino-2-hidroxi-propiloxi)-benzimidazol-2-ona,5-(3-amino-2-hidroxi-propiloxi)-3,4-dihidro-1h-quinazolin-2-ona,5-(3-amino-2-hideoxi-propiloxi)-(1h)(3h)-quina-zolin-2,4-diona,7-(3-amino-2-hidroxi-propiloxi)-2(3h)-benzoxazolona,5-(3-amino-2-hidroxi-propiloxi)-1,2,3,4-tetrahidro-2,3-dioxo-quinoxazolina,8-(3-amino-2-hidroxi-propiloxi)-2,3-dihidro-4-h-benz(5,6)oxazin-3-ona y 7-(3-amino-2-hidroxi-propiloxi)-4h-1,3-benzoxazin-2(1h)ona - Google Patents
Procedimiento para la elaboracion de compuestos de 4-(3-amino-2-hidroxi-propiloxi)-benzimidazol-2-ona,5-(3-amino-2-hidroxi-propiloxi)-3,4-dihidro-1h-quinazolin-2-ona,5-(3-amino-2-hideoxi-propiloxi)-(1h)(3h)-quina-zolin-2,4-diona,7-(3-amino-2-hidroxi-propiloxi)-2(3h)-benzoxazolona,5-(3-amino-2-hidroxi-propiloxi)-1,2,3,4-tetrahidro-2,3-dioxo-quinoxazolina,8-(3-amino-2-hidroxi-propiloxi)-2,3-dihidro-4-h-benz(5,6)oxazin-3-ona y 7-(3-amino-2-hidroxi-propiloxi)-4h-1,3-benzoxazin-2(1h)onaInfo
- Publication number
- AR215643A1 AR215643A1 AR268661A AR26866177A AR215643A1 AR 215643 A1 AR215643 A1 AR 215643A1 AR 268661 A AR268661 A AR 268661A AR 26866177 A AR26866177 A AR 26866177A AR 215643 A1 AR215643 A1 AR 215643A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydroxy
- amino
- propyloxy
- ona
- propyloxi
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH16176A CH624395A5 (es) | 1976-01-08 | 1976-01-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR215643A1 true AR215643A1 (es) | 1979-10-31 |
Family
ID=4180641
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR265940A AR214869A1 (es) | 1976-01-08 | 1976-12-21 | Procedimiento para la elaboracion de compuestos sustituidos por(3-amino-2-hidroxi-propiloxi)de la benzimidazol-2-ona,2-(3h)-benzoxazolona,(1h)(3h)-quinazolin-2,4-diona,3,4-dihidro-1h-quinazolin-2-ona,1,2,3,4-tetrahidro-2,3-dioxo-quinazolina,2,3-dihidro-4h-benze(5,6)oxazin-3-ona y 4h-1,3-benzoxazin-2(1h)-ona |
| AR268662A AR217258A1 (es) | 1976-01-08 | 1977-08-02 | Procedimiento para la elaboracion de compuestos(3-amino-2-hidroxi-propiloxi)-benzimidazol-2-ona,2(3h)-benzoxazolona,(1h)(3h)-quinazolin-2,4-dional,3,4-dihidro-1h-quinazolin-2-ona 1,2,3,4-tetra-dihidro-2,3-dioxo-quinazolina,2,3-hidro-4h-benz(5,6)oxazin-3-ona y 4h-1,3-benzoxazin-2(1h)-(ona) |
| AR268660A AR214746A1 (es) | 1976-01-08 | 1977-08-02 | Procedimiento para la elaboracion de 4-(3-amino-2-hidroxi-propiloxi)-benzimidazol-2-onas y 5-(3-amino-2-hidroxi-propiloxi)-1,2,3,4-tetrahidro-2,3-dioxo-quinoxazolinas |
| AR268661A AR215643A1 (es) | 1976-01-08 | 1977-08-02 | Procedimiento para la elaboracion de compuestos de 4-(3-amino-2-hidroxi-propiloxi)-benzimidazol-2-ona,5-(3-amino-2-hidroxi-propiloxi)-3,4-dihidro-1h-quinazolin-2-ona,5-(3-amino-2-hideoxi-propiloxi)-(1h)(3h)-quina-zolin-2,4-diona,7-(3-amino-2-hidroxi-propiloxi)-2(3h)-benzoxazolona,5-(3-amino-2-hidroxi-propiloxi)-1,2,3,4-tetrahidro-2,3-dioxo-quinoxazolina,8-(3-amino-2-hidroxi-propiloxi)-2,3-dihidro-4-h-benz(5,6)oxazin-3-ona y 7-(3-amino-2-hidroxi-propiloxi)-4h-1,3-benzoxazin-2(1h)ona |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR265940A AR214869A1 (es) | 1976-01-08 | 1976-12-21 | Procedimiento para la elaboracion de compuestos sustituidos por(3-amino-2-hidroxi-propiloxi)de la benzimidazol-2-ona,2-(3h)-benzoxazolona,(1h)(3h)-quinazolin-2,4-diona,3,4-dihidro-1h-quinazolin-2-ona,1,2,3,4-tetrahidro-2,3-dioxo-quinazolina,2,3-dihidro-4h-benze(5,6)oxazin-3-ona y 4h-1,3-benzoxazin-2(1h)-ona |
| AR268662A AR217258A1 (es) | 1976-01-08 | 1977-08-02 | Procedimiento para la elaboracion de compuestos(3-amino-2-hidroxi-propiloxi)-benzimidazol-2-ona,2(3h)-benzoxazolona,(1h)(3h)-quinazolin-2,4-dional,3,4-dihidro-1h-quinazolin-2-ona 1,2,3,4-tetra-dihidro-2,3-dioxo-quinazolina,2,3-hidro-4h-benz(5,6)oxazin-3-ona y 4h-1,3-benzoxazin-2(1h)-(ona) |
| AR268660A AR214746A1 (es) | 1976-01-08 | 1977-08-02 | Procedimiento para la elaboracion de 4-(3-amino-2-hidroxi-propiloxi)-benzimidazol-2-onas y 5-(3-amino-2-hidroxi-propiloxi)-1,2,3,4-tetrahidro-2,3-dioxo-quinoxazolinas |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US4140789A (es) |
| JP (1) | JPS5285166A (es) |
| AR (4) | AR214869A1 (es) |
| AT (1) | AT355564B (es) |
| AU (1) | AU507884B2 (es) |
| BE (1) | BE850166A (es) |
| CA (1) | CA1083150A (es) |
| CH (1) | CH624395A5 (es) |
| CS (1) | CS201040B2 (es) |
| DD (1) | DD129444A5 (es) |
| DE (1) | DE2700193A1 (es) |
| DK (1) | DK6177A (es) |
| ES (1) | ES454779A1 (es) |
| FI (1) | FI770036A (es) |
| FR (1) | FR2337718A1 (es) |
| GB (1) | GB1549945A (es) |
| GR (1) | GR73132B (es) |
| IE (1) | IE44246B1 (es) |
| IL (1) | IL51222A (es) |
| NL (1) | NL7700141A (es) |
| NO (1) | NO770061L (es) |
| NZ (1) | NZ182963A (es) |
| PL (4) | PL112441B1 (es) |
| SE (1) | SE7700056L (es) |
| SU (4) | SU648091A3 (es) |
| ZA (1) | ZA7787B (es) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH624395A5 (es) * | 1976-01-08 | 1981-07-31 | Ciba Geigy Ag | |
| DE2644833A1 (de) * | 1976-10-05 | 1978-04-20 | Boehringer Sohn Ingelheim | Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung |
| NZ187066A (en) * | 1977-05-03 | 1981-02-11 | Hoffmann La Roche | 4-(3-substitutedamino-2-hydroxypropoxy)-benzimidazolidin-2-(ones or thiones) |
| CA1108619A (en) * | 1977-08-12 | 1981-09-08 | Carl H. Ross | 4-hydroxy-2-benzimidazolinone derivatives and the preparation thereof |
| DE2801980A1 (de) * | 1978-01-18 | 1979-07-19 | Boehringer Mannheim Gmbh | 4-hydroxy-2-benzimidazolin-thion- derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
| EP0003758A1 (de) * | 1978-02-09 | 1979-09-05 | Ciba-Geigy Ag | Verätherte Hydroxy-benzodiheterocyclen und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate |
| DE2905877A1 (de) * | 1979-02-16 | 1980-08-28 | Boehringer Mannheim Gmbh | Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DD150456A5 (de) * | 1979-03-01 | 1981-09-02 | Ciba Geigy Ag | Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols |
| SE8003277L (sv) | 1979-05-04 | 1980-11-05 | Continental Pharma | Bensimidazolderivat, deras framstellning och anvendning samt kompositioner innehallande dessa derivat |
| DE2922084A1 (de) | 1979-05-31 | 1980-12-11 | Boehringer Mannheim Gmbh | Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US4331679A (en) * | 1980-12-23 | 1982-05-25 | Merck Sharp & Dohme (I.A.) Corp. | (3-Aralkylamino-2-or-propoxy) heterocyclic compounds |
| US4656168A (en) * | 1980-12-23 | 1987-04-07 | Merck & Co., Inc. | (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation |
| US4349673A (en) * | 1980-12-23 | 1982-09-14 | Merck & Co., Inc. | Benzoxazines |
| US4442094A (en) * | 1980-12-23 | 1984-04-10 | Merck & Co., Inc. | (3-Aralkylamino-2-or-propoxy)heterocyclic compounds |
| DE3217012A1 (de) * | 1982-05-06 | 1983-11-10 | Dr. Karl Thomae Gmbh, 7950 Biberach | Benzoxazin-2-one, deren herstellung und diese verbindungen enthaltende arzneimittel |
| IT1212552B (it) * | 1982-10-20 | 1989-11-30 | Italo Britannica L Manet Ti H | Alcanolaminossi derivati di 3,4-diidro-2h-1.4-benzotiazin-3-one, loro procedimento di produzione e loro utilizzazione farmaceutica |
| GB8419797D0 (en) * | 1984-08-03 | 1984-09-05 | Beecham Group Plc | Compounds |
| DE3800096A1 (de) * | 1988-01-05 | 1989-07-13 | Bayer Ag | Verwendung von benzimidazolderivaten als leistungsfoerderer |
| FR2653430B1 (fr) * | 1989-10-23 | 1991-12-20 | Pf Medicament | Nouveaux derives de dihydro-1,2 oxo-2 quinoxalines, leur preparation et leur application en therapeutique. |
| ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
| EP0827746B1 (en) | 1996-09-05 | 2002-04-03 | Eli Lilly And Company | Carbazole analogues as selective beta3 adrenergic agonists |
| US5808080A (en) * | 1996-09-05 | 1998-09-15 | Eli Lilly And Company | Selective β3 adrenergic agonists |
| US5990144A (en) * | 1997-02-18 | 1999-11-23 | American Home Products Corporation | 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autoreceptor agonists |
| US5922715A (en) * | 1997-02-18 | 1999-07-13 | American Home Products Corporation | 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones |
| US5972958A (en) * | 1997-02-18 | 1999-10-26 | American Home Products Corporation | 4-aminoalkoxy-1,3-dihydro-benzoimidazol-2-thiones |
| DE59804641D1 (de) * | 1997-09-24 | 2002-08-08 | Infineon Technologies Ag | o-Nitro(thio)phenolderivate und deren Herstellung |
| CO5011072A1 (es) | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
| WO2001036412A1 (en) * | 1999-11-15 | 2001-05-25 | Eli Lilly And Company | Process for the preparation of aryloxy propanolamines |
| FR2805159B1 (fr) | 2000-02-23 | 2005-06-10 | Oreal | Compositions pour la teinture d'oxydation des fibres keratiniques comprenant un n-(2-hydroxybenzene)-carbamate ou un n-(2-hydroxybenzene)-uree a titre de coupleur, et procedes de teinture |
| JP2004513164A (ja) | 2000-11-10 | 2004-04-30 | イーライ・リリー・アンド・カンパニー | ３−置換オキシインドールβ３アゴニスト |
| EP1421078B1 (en) | 2001-08-14 | 2006-09-27 | Eli Lilly And Company | Indole derivatives as beta-3 adrenergic agonists for the treatment of type 2 diabetes |
| EP1444224B1 (en) | 2001-08-14 | 2006-05-03 | Eli Lilly And Company | 3-substituted oxindole beta-3 agonists |
| DE60204718T2 (de) | 2001-11-20 | 2006-05-18 | Eli Lilly And Co., Indianapolis | 3-substituierte oxindol beta 3 agonisten |
| AU2002353844A1 (en) | 2001-11-20 | 2003-06-10 | Eli Lilly And Company | Beta 3 adrenergic agonists |
| US7009060B2 (en) | 2002-01-11 | 2006-03-07 | Eli Lilly And Company | 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| ES2353383T3 (es) * | 2002-08-29 | 2011-03-01 | Nissan Chemical Industries, Ltd. | Procedimiento de producción de un compuesto de aminobenzopirano. |
| AU2004259703A1 (en) * | 2003-07-15 | 2005-02-03 | Smithkline Beecham Corporation | Novel compounds |
| WO2008041118A2 (en) * | 2006-10-04 | 2008-04-10 | Pfizer Products Inc. | Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
| WO2014108449A1 (en) | 2013-01-08 | 2014-07-17 | Atrogi Ab | A screening method, a kit, a method of treatment and a compound for use in a method of treatment |
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA726737A (en) * | 1966-01-25 | C. Scarborough Homer | 4-substituted quinolines and quinazolines | |
| US3686176A (en) * | 1970-03-09 | 1972-08-22 | Frosst & Co Charles E | 1-morpholino phenoxy-3-alkylamino-2-propanols |
| US3763153A (en) * | 1972-02-22 | 1973-10-02 | Squibb & Sons Inc | Benzothiazines |
| GB1488330A (en) * | 1973-12-19 | 1977-10-12 | Smith Kline French Lab | Dihydropyridazinones |
| CH624395A5 (es) * | 1976-01-08 | 1981-07-31 | Ciba Geigy Ag |
-
1976
- 1976-01-08 CH CH16176A patent/CH624395A5/de not_active IP Right Cessation
- 1976-12-16 US US05/751,233 patent/US4140789A/en not_active Expired - Lifetime
- 1976-12-21 AR AR265940A patent/AR214869A1/es active
- 1976-12-22 NZ NZ182963A patent/NZ182963A/xx unknown
- 1976-12-22 GB GB53633/76A patent/GB1549945A/en not_active Expired
-
1977
- 1977-01-04 ES ES454779A patent/ES454779A1/es not_active Expired
- 1977-01-04 SE SE7700056A patent/SE7700056L/xx unknown
- 1977-01-04 DE DE19772700193 patent/DE2700193A1/de not_active Withdrawn
- 1977-01-06 PL PL1977214709A patent/PL112441B1/pl unknown
- 1977-01-06 FI FI770036A patent/FI770036A/fi not_active Application Discontinuation
- 1977-01-06 FR FR7700232A patent/FR2337718A1/fr active Granted
- 1977-01-06 AU AU21105/77A patent/AU507884B2/en not_active Expired
- 1977-01-06 CA CA269,205A patent/CA1083150A/en not_active Expired
- 1977-01-06 PL PL1977195154A patent/PL110654B1/pl unknown
- 1977-01-06 PL PL1977214710A patent/PL112442B1/pl unknown
- 1977-01-06 DD DD7700196843A patent/DD129444A5/xx unknown
- 1977-01-06 PL PL1977214708A patent/PL112491B1/pl unknown
- 1977-01-06 IL IL51222A patent/IL51222A/xx unknown
- 1977-01-07 IE IE31/77A patent/IE44246B1/en unknown
- 1977-01-07 DK DK6177A patent/DK6177A/da unknown
- 1977-01-07 CS CS77117A patent/CS201040B2/cs unknown
- 1977-01-07 AT AT4677A patent/AT355564B/de not_active IP Right Cessation
- 1977-01-07 NL NL7700141A patent/NL7700141A/xx not_active Application Discontinuation
- 1977-01-07 ZA ZA770087A patent/ZA7787B/xx unknown
- 1977-01-07 SU SU772435952A patent/SU648091A3/ru active
- 1977-01-07 BE BE173895A patent/BE850166A/xx unknown
- 1977-01-07 NO NO770061A patent/NO770061L/no unknown
- 1977-01-08 JP JP55977A patent/JPS5285166A/ja active Pending
- 1977-01-08 GR GR52536A patent/GR73132B/el unknown
- 1977-08-02 AR AR268662A patent/AR217258A1/es active
- 1977-08-02 AR AR268660A patent/AR214746A1/es active
- 1977-08-02 AR AR268661A patent/AR215643A1/es active
- 1977-09-29 SU SU772525452A patent/SU648092A3/ru active
- 1977-09-29 SU SU772525901A patent/SU651695A3/ru active
- 1977-09-29 SU SU772526202A patent/SU645568A3/ru active
-
1979
- 1979-03-08 US US06/018,397 patent/US4310527A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR215643A1 (es) | Procedimiento para la elaboracion de compuestos de 4-(3-amino-2-hidroxi-propiloxi)-benzimidazol-2-ona,5-(3-amino-2-hidroxi-propiloxi)-3,4-dihidro-1h-quinazolin-2-ona,5-(3-amino-2-hideoxi-propiloxi)-(1h)(3h)-quina-zolin-2,4-diona,7-(3-amino-2-hidroxi-propiloxi)-2(3h)-benzoxazolona,5-(3-amino-2-hidroxi-propiloxi)-1,2,3,4-tetrahidro-2,3-dioxo-quinoxazolina,8-(3-amino-2-hidroxi-propiloxi)-2,3-dihidro-4-h-benz(5,6)oxazin-3-ona y 7-(3-amino-2-hidroxi-propiloxi)-4h-1,3-benzoxazin-2(1h)ona | |
| ES514585A0 (es) | Procedimiento para la obtencion de derivados de oxazol trisustituidos. | |
| ES491514A0 (es) | Procedimiento para la obtencion de nuevos compuestos de 2- (pirimidinilamino)-1,3-diaza-2-cicloalqueno | |
| NO154919C (no) | Analogifremgangsmaate ved fremstilling av nye kinazolinderivater. | |
| NO802073L (no) | Fremgangsmaate ved fremstilling av antihypertensive amider | |
| SE8102420L (sv) | Nya 2-arylpropyleter- eller -tioeterderivat, forfarande for framstellning derav och insekticida och akaricida medel innehallande derivaten | |
| TR21512A (tr) | 4h-3,1 benzoksazin tuerevleri | |
| NO794327L (no) | Fremgangsmaate ved fremstilling av nye peptidylargininaldehyd-derivater. | |
| AR230986A1 (es) | Derivados de 4-((2-cloro-4-trifluorometil)-fenoxi)-fenil-carbonil o carboxi-oximas alfa substituidas y compuestos intermedios para la preparacion de los mismos | |
| DK148260C (da) | Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf | |
| ES487629A0 (es) | Procedimiento para la preparacion de nuevos derivados de alfa-(3,4-diclorofenil)-2-imidazolina-2-metanol y alfa-(3,4-diclorofenil)-1,4,5,6-tetrahidro-2-pirimidinametanol | |
| NO770457L (no) | Fremgangsm}te ved fremstilling av kondenserte pyrimidinderivater. | |
| ES493984A0 (es) | Procedimiento para la preparacion de nuevos derivados de urea | |
| NO800664L (no) | Analogifremgangsmaate for fremstilling av hydroksypyrimidinderivater | |
| NO156086C (no) | Analogifremgangsmaate for fremstilling av substituerte heterocykliske fenoksyaminer. | |
| AR225611A1 (es) | Procedimiento para la obtencion de nuevos derivados 5-halogen-6-(2',4'-dihalofenoxi)-1(o 3)-sustituido-2h-1,3-dihidrobenzimidazol-2-tiona,o similares | |
| AR217426A1 (es) | Procedimiento para la preparacion de nuevos derivados de 7-(3-indoliloxi,naftiloxi o fenoxi-2-hidroxi-propilamino-alquil)-teofilina | |
| SE7700533L (sv) | Forfarande for framstellning av 3,4-dihydro-2(1h)-kinazolinonderivat | |
| AR219924A1 (es) | Procedimiento de preparacion de nuevos derivados de 7-cloro-3-alcoxi (c1-c4) carbonil-5-(2-halofenil) -2-oxo-2,3-dihidro- (1h) -1,4 benzodiacepinas | |
| ES494535A0 (es) | Procedimiento para la obtencion de derivados de la tetrahi- droquinolina | |
| FI791171A (fi) | Foerfarande och anordning foer identifiering av mynt eller liknande | |
| FI790320A (fi) | Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan | |
| AR229174A1 (es) | Procedimiento para la preparacion de nuevas 4-(3-trifluormetilfenil)-1,2,3,6-tetrahidropiridinas | |
| ES489372A0 (es) | Procedimiento para preparar nuevos derivados de 2,2-dime- til-1,2-dihidroquinolina | |
| AR216675A1 (es) | Procedimiento para la preparacion de 2-(gamma-(1-piperidinil)propil)-1,2-benzisotiazol-3-ona |